C57BL/6JCya-Mycbp2em1flox/Cya
Common Name:
Mycbp2-flox
Product ID:
S-CKO-00467
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Mycbp2-flox
Strain ID
CKOCMP-105689-Mycbp2-B6J-VA
Gene Name
Product ID
S-CKO-00467
Gene Alias
C130061D10Rik; Pam; Phr1
Background
C57BL/6JCya
NCBI ID
Modification
Conditional knockout
Chromosome
14
Phenotype
Document
Application
--
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Mycbp2em1flox/Cya mice (Catalog S-CKO-00467) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000159855
NCBI RefSeq
NM_207215
Target Region
Exon 4
Size of Effective Region
~1.5 kb
Detailed Document
Overview of Gene Research
MYCBP2, also known as PAM or Phr1, is an atypical really interesting new gene (RING) ubiquitin ligase and signalling hub. It is involved in diverse processes such as neuronal connectivity, synaptic growth, cell division, neuronal survival, and protein ubiquitination. It participates in pathways related to axon development, immune response regulation, and lipid metabolism, and is of great biological importance [1,4,5]. Genetic models like Caenorhabditis elegans are valuable for studying MYCBP2.
Loss-of-function variants in MYCBP2 in patients lead to neurobehavioural phenotypes and corpus callosum defects. Nuclease technology-mediated introduction of disease-associated variants into the C. elegans MYCBP2 orthologue, RPM-1, showed axonal and behavioural abnormalities, suggesting MYCBP2 variants likely result in loss of function [1]. In spinal cord injury, MYCBP2 delivered via ginsenoside Rg1-pretreated neuronal cell-derived extracellular vesicles promotes microglial M2-phenotype polarization and reduces oxidative stress, thus enhancing neurological recovery [2]. In thyroid cancer, high MYCBP2 expression is associated with increased infiltration of immune cells, better prognosis, and higher sensitivity to immunotherapy, suggesting it may be a predictive biomarker for immune checkpoint inhibitor efficacy [3]. In MASH-associated hepatocellular carcinoma, MYCBP2 acts as a potential tumor suppressor by modulating lipid metabolism through promoting the ubiquitination and degradation of HNF4α [4]. In breast cancer, dysregulation of MYCBP2 is accompanied by decreased disease-free survival, and its loss confers resistance to apoptosis from cisplatin-induced DNA damage [6].
In conclusion, MYCBP2 is crucial for normal biological functions, especially in neural development, immune response, and cancer-related processes. Studies using model organisms and patient-derived data have revealed its role in various disease conditions, including neurodevelopmental disorders, spinal cord injury, thyroid cancer, hepatocellular carcinoma, and breast cancer. These findings provide insights into potential therapeutic targets related to MYCBP2-associated pathways.
References:
1. AlAbdi, Lama, Desbois, Muriel, Rusnac, Domniţa-Valeria, Grill, Brock, Alkuraya, Fowzan S. . Loss-of-function variants in MYCBP2 cause neurobehavioural phenotypes and corpus callosum defects. In Brain : a journal of neurology, 146, 1373-1387. doi:10.1093/brain/awac364. https://pubmed.ncbi.nlm.nih.gov/36200388/
2. Rong, Yuluo, Wang, Jiaxing, Hu, Tao, Zhang, Feng, Zhang, Wenzhi. 2024. Ginsenoside Rg1 Regulates Immune Microenvironment and Neurological Recovery After Spinal Cord Injury Through MYCBP2 Delivery via Neuronal Cell-Derived Extracellular Vesicles. In Advanced science (Weinheim, Baden-Wurttemberg, Germany), 11, e2402114. doi:10.1002/advs.202402114. https://pubmed.ncbi.nlm.nih.gov/38896802/
3. Wang, Guilin, Miao, Chen, Mo, Lijun, Pang, Weiyi, Shi, Wenjie. 2022. MYCBP2 expression correlated with inflammatory cell infiltration and prognosis immunotherapy in thyroid cancer patients. In Frontiers in immunology, 13, 1048503. doi:10.3389/fimmu.2022.1048503. https://pubmed.ncbi.nlm.nih.gov/36582246/
4. Zhang, Hao, Kong, Xiangxu, Qu, Haoran, Zhai, Xiangyu, Jin, Bin. 2025. MYCBP2-mediated HNF4α ubiquitination reprogrammed lipid metabolism in MASH-associated hepatocellular carcinoma. In Oncogene, , . doi:10.1038/s41388-025-03373-5. https://pubmed.ncbi.nlm.nih.gov/40181155/
5. Chang, Chao, Banerjee, Sara L, Park, Sung Soon, Grill, Brock, Kania, Artur. 2024. Ubiquitin ligase and signalling hub MYCBP2 is required for efficient EPHB2 tyrosine kinase receptor function. In eLife, 12, . doi:10.7554/eLife.89176. https://pubmed.ncbi.nlm.nih.gov/38289221/
6. Neff, Ryan A, Bosch-Gutierrez, Almudena, Sun, Yifei, Walsh, Martin J, Zhang, Bin. 2023. Dysfunction of ubiquitin protein ligase MYCBP2 leads to cell resilience in human breast cancers. In NAR cancer, 5, zcad036. doi:10.1093/narcan/zcad036. https://pubmed.ncbi.nlm.nih.gov/37435531/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen